4170 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Vectorite Biomedical, Inc. engages in the provision of immune cell storage, biotechnology service, and test service. Its business includes preparation sales, immune cell collection and storage, and medical intermediary. Its products and services include dendritic cell vaccine (DC vaccine), anti-malignant natural killer cell (NK cell) preparation, immune cell storage service, and cell preparation safety testing service. The company was founded on December 23, 2004 and is headquartered in New Taipei, Taiwan.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
4170 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company